Novavax reported $788K in Ordinary Share Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adma Biologics ADMA:US $ 0.02M 0M
Agenus AGEN:US $ 2.83M 0.16M
AstraZeneca AZN:LN 387M 0M
Astrazeneca AZN:US $ 387M 0M
Dynavax Technologies DVAX:US $ 0.13M 0M
Genocea Biosciences GNCA:US $ 0.06M 0M
Geron GERN:US $ 0.38M 0.05M
GlaxoSmithKline GSK:LN 134700M 0M
Mannkind MNKD:US $ 2.57M 0.05M
Minerva Neurosciences NERV:US $ 0M 0M
Moderna Inc MRNA:US 39.2K 800
Novartis NVS:US $ 890M 11M
Novavax NVAX:US $ 0.79M 0M
Pain Therapeutics PTIE:US $ 0.04M 0M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M